MedTrace Logo

Observance of Long Term Oxygen Therapy in Chronic Inspiratory Disease Patients

NCT03188588 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 120

Last updated 2020-09-23

No results posted yet for this study

Summary

Long-term oxygen therapy (LTOT) is the reference treatment for chronic respiratory failure. This treatment is based on the principle of oxygen supplementation via a source to correct hypoxemia in patients. At present, adherence to this treatment is difficult to evaluate (reporting by patients), but the results of the literature show poor LTOT compliance. It is therefore important to accurately measure the oxygen consumption by patients and to understand the factors explaining LTOT compliance. The ultimate aim is to improve our patient management to make them more observant in order to improve the therapeutic efficacy of the treatment.

Conditions

  • Chronic Respiratory Disease
  • Hypoxemia

Sponsors & Collaborators

  • CHU Arnaud de Villeneuve MONTPELLIER

    collaborator UNKNOWN

  • SOS Oxygene Mediterranee

    lead INDUSTRY

Principal Investigators

  • Arnaud Bourdin, Professor · CHU Montpellier, France

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2019-01-31
Completion
2020-01-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03188588 on ClinicalTrials.gov